Biologics: Investing in the Future of Canadian Healthcare Sponsored GSK’s Enduring Leadership in Respiratory Care: Shaping the Future for Patients Sponsored Navigating the RSV Threat: Pharmacist Perspective — Prevention Strategies for At-Risk Adults Top news stories for Canadian pharmacists Your one-stop-shop for global headlines for pharmacists on the clinical to the political, and everything in between! Shingles is awful, but here’s another reason to get vaccinated: It may fight dementia A new study found shingles vaccination cut older adults’ risk of developing dementia over the next seven years by 20%. Updated Canadian guidance on use of RSV vaccines in older adults National Advisory Committee on Immunization’s update also addresses use of new RSV mRNA vaccine (mResvia) and an expanded age range for Arexvy. Ottawa purchases 500,000 bird flu vaccine doses to help protect people most at risk Health Minister Mark Holland said Wednesday in a release the move is among the ‘proactive steps’ to prepare for the threat of H5N1 spread. Pharma-tariffs If the U.S. goes ahead with its tariffs, we can expect tariffs on drugs and Canada to retaliate with similar measures, warns pharmacy industry expert Bertrand Bolduc. U.S. FDA issues new warning for RSV vaccines Arexvy and Abrysvo Either vaccine may slightly increase the risk of Guillain-Barré syndrome within 42 days of administration. Build vaccine stockpile, use wastewater testing for H5N1 bird flu, experts urge There are no indications that H5N1 bird flu would spark a pandemic, but experts urged preparedness. 1 2 3 4 5 Next Last
